secwatch.observer — SEC 8-K summary
======================================

Issuer:     BiomX Inc. (PHGE)
CIK:        0001739174
Form:       8-K
Filed at:   2026-03-06T23:59:59+00:00
Accession:  0001213900-26-024344
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BiomX CEO and Chairman resign; Michael Oster appointed new CEO, Amir Shalom joins board
--------------------------------------------------------------------------------

- Jonathan Solomon resigned as CEO and director effective March 4, 2026; no disagreement with company.
- Dr. Russell Greig resigned as Chairman and director effective same date; no disagreement cited.
- Board appointed Michael Oster as CEO; previously CEO of Saffron Tech Ltd. and Sattivus Tech Corp.
- Board appointed Amir Shalom as Class I director; operations manager at Barzilai Medical Center.
- New committee assignments: Liat Bidas chairs Audit; Amir Shalom chairs Compensation; Liat Bidas chairs Nominating and Governance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026024344/0001213900-26-024344-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1739174/000121390026024344/ea0280337-8k_biomx.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-024344

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer